1. Search Result
Search Result
Results for "

BMS-901608

" in MedChemExpress (MCE) Product Catalog:
Cat. No. Product Name Target Research Area
  • HY-P9965

    HuLuc 63; PDL 063; BMS 901608

    Inhibitory Antibodies Cancer
    Elotuzumab is a monoclonal antibody directed against the SLAMF7 receptor. Elotuzumab has no significant antimyeloma activity when given as a single agent with relapsed or refractory multiple myeloma (RRMM). Elotuzumab results in improved response and outcome when combined with other antimyeloma agents .